Creating a Selective Nanobody Against 3-Nitrotyrosine Containing Proteins

A critical step in developing therapeutics for oxidative stress-related pathologies is the ability to determine which specific modified protein species are innocuous by-products of pathology and which are causative agents. To achieve this goal, technologies are needed that can identify, characterize...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Fossen, Elise M., Grutzius, Sonia, Ruby, Carl E., Mourich, Dan V., Cebra, Chris, Bracha, Shay, Karplus, P. Andrew, Cooley, Richard B., Mehl, Ryan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899190/
https://www.ncbi.nlm.nih.gov/pubmed/35265586
http://dx.doi.org/10.3389/fchem.2022.835229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899190/
https://www.ncbi.nlm.nih.gov/pubmed/35265586
http://dx.doi.org/10.3389/fchem.2022.835229

Ejemplares similares